Voisin Consulting Life Sciences webinar icon
Webinar

What are the reimbursement pathways for innovative digital health technologies?

Post thumbnail What are the reimbursement pathways for innovative digital health technologies?

Innovative digital health solutions are finding their ways into routine patient care in the US and Europe, and different payers are starting to cover software-based healthcare products just like they may cover pills and physician visits. But precisely which digital technologies get reimbursed and how? Is this a business model that could work for your product(s)?  In this webinar, VCLS Market Access experts from the US and EU will outline the environment and possibilities for digital health reimbursement in key markets. The discussions will give an overview of the dynamic policy environments in US, France, Germany and provide answers to questions such as:

  • What digital products are eligible for reimbursement?
  • What are the pathways to obtain reimbursement and the related challenges?
  • What role do new payment models play?
Voisin Consulting Life Sciences download icon

Register to this webinar now

What are the reimbursement pathways for innovative digital health technologies?

Feb 16, 202116:00 CET1 hour

Convert to my timezone

Innovative digital health solutions are finding their ways into routine patient care in the US and Europe, and different payers are starting to cover software-based healthcare products just like they may cover pills and physician visits. But precisely which digital technologies get reimbursed and how? Is this a business model that could work for your product(s)? In this webinar, VCLS Market Access experts from the US and EU will outline the environment and possibilities for digital health reimbursement in key markets. The discussions will give an overview of the dynamic policy environments in US, France, Germany and provide answers to questions such as:

What digital products are eligible for reimbursement?
What are the pathways to obtain reimbursement and the related challenges?
What role do new payment models play?

Featured Speakers

Randy Goodman
Randy Goodman, PhD, MHA, FACHE
U.S. Market Access Engagement Director
As a Director in the U.S. Market Access Team, Randy is responsible for the development of Voisin Consulting Life Sciences…
View profile
Henrike Granzow
Henrike Granzow, M.Sc.
Director, Market Access
As a Director in the Market Access Team, Henrike is responsible for developing successful market access and reimbursement strategies, on…
View profile
Paul Toscano thumbnail
Paul Toscano
Director, Business Development and Key Accounts US